Fjarde Ap Fonden Dexcom Inc Transaction History

Fjarde Ap Fonden

$9.8 Billion
Q3 2024

A detailed history of Fjarde Ap Fonden transactions in Dexcom Inc stock. As of the latest transaction made, Fjarde Ap Fonden holds 66,044 shares of DXCM stock, worth $5.3 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

66,044

Previous 55,844 18.27%

Holding current value

$5.3 Million

Previous $7.75 Million 42.84%

% of portfolio

0.05%

Previous 0.09%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$64.0 - $116.06 $652,800 - $1.18 Million	10,200 Added 18.27%	66,044 $4.43 Million
Q1 2024 Apr 25, 2024	BUY	$114.22 - $140.1 $91,376 - $112,080	800 Added 1.45%	55,844 $7.75 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $377,450 - $620,800	5,000 Added 9.99%	55,044 $6.83 Million
Q3 2023 Oct 23, 2023	SELL	$86.06 - $137.93 $611,026 - $979,303	-7,100 Reduced 12.42%	50,044 $4.67 Million
Q2 2023 Aug 02, 2023	BUY	$112.47 - $130.98 $978,489 - $1.14 Million	8,700 Added 17.96%	57,144 $7.34 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $780,000 - $921,900	-7,500 Reduced 13.41%	48,444 $5.63 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $1.1 Million - $1.58 Million	-12,900 Reduced 18.74%	55,944 $6.34 Million
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $3.1 Million - $6.06 Million	45,633 Added 196.6%	68,844 $5.13 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $206,976 - $286,440	-2,200 Reduced 8.66%	23,211 $11.9 Million
Q4 2021 Feb 15, 2022	SELL	$129.87 - $162.82 $167,792 - $210,363	-1,292 Reduced 4.84%	25,411 $13.6 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $10,671 - $14,318	-100 Reduced 0.37%	26,703 $14.6 Million
Q2 2021 Aug 12, 2021	SELL	$80.99 - $107.93 $137,683 - $183,481	-1,700 Reduced 5.96%	26,803 $11.4 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $33,916 - $41,896	400 Added 1.42%	28,503 $10.2 Million
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $70,200 - $94,050	900 Added 3.31%	28,103 $10.4 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $85,959 - $101,655	900 Added 3.42%	27,203 $11.2 Million
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $351,008 - $589,904	-5,600 Reduced 17.55%	26,303 $10.7 Million
Q1 2020 May 11, 2020	BUY	$47.79 - $75.63 $52,569 - $83,193	1,100 Added 3.57%	31,903 $8.59 Million
Q4 2019 Feb 10, 2020	BUY	$36.62 - $57.29 $84,226 - $131,767	2,300 Added 8.07%	30,803 $6.74 Million
Q3 2019 Oct 31, 2019	BUY	$35.53 - $43.8 $67,116 - $82,738	1,889 Added 7.1%	28,503 $4.25 Million
Q2 2019 Jul 17, 2019	SELL	$27.84 - $38.92 $119,712 - $167,356	-4,300 Reduced 13.91%	26,614 $3.99 Million
Q1 2019 Apr 29, 2019	BUY	$28.07 - $38.18 $143,549 - $195,252	5,114 Added 19.82%	30,914 $3.68 Million
Q4 2018 Jan 31, 2019	BUY	$26.99 - $37.37 $696,342 - $964,145	25,800 New	25,800 $3.09 Million
Q4 2017 Feb 12, 2018	SELL	$11.12 - $15.38 $266,501 - $368,597	-23,966 Closed	0 $0
Q3 2017 Nov 07, 2017	SELL	$11.36 - $18.98 $15,358 - $25,660	-1,352 Reduced 5.34%	23,966 $1.17 Million
Q2 2017 Aug 08, 2017	BUY	N/A	25,318	25,318 $1.85 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account